Related Experiment Video

Updated: Sep 17, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

16.2K

Thrombotic Microangiopathies

Ramy Hanna1, Ryan Gibney2, Megan Boysen-Osborn2

  • 1Division of Nephrology, Department of Medicine, University of California, 101 The City Drive, Orange, CA 92868, USA.

Emergency Medicine Clinics of North America
|July 3, 2025
PubMed

Insights

Thrombotic microangiopathies (TMAs) are rare vascular disorders causing blood clots. Early diagnosis and evaluation are vital for managing these serious conditions, including thrombotic thrombocytopenic purpura (TTP), to improve patient outcomes.

Area of Science:

  • Hematology
  • Internal Medicine
  • Pathology

Background:

  • Thrombotic microangiopathies (TMAs) are a group of rare, serious diseases.
  • They involve endothelial injury and the formation of microvascular blood clots.
  • TMAs can result in microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage.

Purpose of the Study:

  • To highlight the diagnostic challenges of TMAs in emergency settings.
  • To emphasize the importance of early recognition and evaluation for TMAs.
  • To discuss the critical role of laboratory tests in diagnosing TMAs.

Main Methods:

  • Review of clinical presentations and diagnostic criteria for TMAs.
  • Analysis of common laboratory findings, including complete blood count and peripheral smear.
  • Discussion of specific TMA types like thrombotic thrombocytopenic purpura (TTP).

Main Results:

  • TMAs are characterized by endothelial injury and microvascular thrombosis.
  • Key clinical features include hemolytic anemia and thrombocytopenia.
  • Thrombotic thrombocytopenic purpura (TTP) presents with severe thrombocytopenia, hemolytic anemia, and normal coagulation factors.

Conclusions:

  • Diagnosing TMAs in emergency departments is complex.
  • Prompt laboratory evaluation is essential for timely diagnosis.
  • Early recognition and management of TMAs, particularly TTP, are crucial for reducing mortality and improving patient outcomes.
Keywords:
ADAMTS13 deficiencyEmergency diagnosis and laboratory testingMicroangiopathic hemolytic anemiaThrombotic microangiopathiesThrombotic thrombocytopenic purpura

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.9K

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
45
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
41
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
50